Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a University Hospital in Northeastern Iran

Journal of Clinical Microbiology

Volumn 50, Issue 11, 2012, Pages 3581-3585

  Azimian, Amir ^a   Havaei, Seyed Asghar ^a   Fazeli, Hosein ^a   Naderi, Mahmood ^b,c   Ghazvini, Kiarash ^d   Samiee, Siamak Mirab ^e   Soleimani, Masoud ^b   Peerayeh, Shahin Najar ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c STEM CELL TECHNOLOGY RESEARCH CENTER   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; HYDROCORTISONE; KETOCONAZOLE; LEVOFLOXACIN; METICILLIN; METRONIDAZOLE; MINOCYCLINE; OXACILLIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ABDOMINAL DISEASE; ACINETOBACTER BAUMANNII; ADULT; AGR GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM ISOLATE; BRONCHIAL ASPIRATION PROCEDURE; CASE REPORT; CONTROLLED STUDY; GENETIC ANALYSIS; HUMAN; INFLAMMATION; MALE; MECA GENE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PERITONITIS; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY SYSTEM; SCCMEC GENE; SEPTICEMIA; SPA GENE; STAPHYLOCOCCUS INFECTION; VANA GENE; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CARBON-OXYGEN LIGASES; HOSPITALS, UNIVERSITY; HUMANS; IRAN; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PLASMIDS; POLYMERASE CHAIN REACTION; RESPIRATORY SYSTEM; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 84867519930     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01727-12     Document Type: Article

References (40)

1. Aligholi M, et al. 2008. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med. Princ. Pract. 17:432-434.
2. Boye K, Bartels MD, Andersen IS, Møller JA, Westh H. 2007. A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V. Clin. Microbiol. Infect. 13:725-727. (Pubitemid 46909351)
3. Bozdogan B, Ednie L, Credito K, Kosowska K, Appelbaum PC. 2004. Derivatives of a vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical Center. Antimicrob. Agents Chemother. 48:4762-4765. (Pubitemid 39577682)
4. Bush K. 2004. Vancomycin-resistant Staphylococcus aureus in the clinic: not quite Armageddon. Clin. Infect. Dis. 38:1056-1057. (Pubitemid 38951247)
5. Centers for Disease Control and Prevention. 1997. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin.MMWRMorb. Mortal. Wkly. Rep. 46:626-628, 635.
6. Centers for Disease Control and Prevention. 2002. Vancomycin-resistant Staphylococcus aureus - Pennsylvania. MMWR Morb. Mortal. Wkly. Rep. 51:902.
7. Centers for Disease Control and Prevention. 2004. Vancomycin-resistant Staphylococcus aureus - New York, 2004. MMWR Morb. Mortal. Wkly. Rep. 53:322-323.
8. Chang S, et al. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348:1342-1347. (Pubitemid 36384101)
9. Chen H, Liu Y, Jiang X, Chen M, Wang H. 2010. Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese tertiary care hospital over a 15-year period. Antimicrob. Agents Chemother. 54:1842-1847.
10. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing, 20th informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial disk susceptibility tests. Approved standard, 11th ed. CLSI document M02-A11. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Dezfulian A, et al. 2012. Identification and characterization of a high vancomycin-resistant Staphylococcus aureus harboring VanA gene cluster isolated from diabetic foot ulcer. Iran. J. Basic Med. Sci. 15:803-806.
13. Enright MC, Day PJ, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015. (Pubitemid 30140551)
14. Finks J, et al. 2009. Vancomycin-resistant Staphylococcus aureus, Michigan, U. S. A., 2007. Emerg. Infect. Dis. 15:943-945.
15. Flannagan SE, et al. 2003. Plasmid content of a vancomycin-resistant Enterococcus faecalis isolate from a patient also colonized by Staphylococcus aureus with a VanA phenotype. Antimicrob. Agents Chemother. 47:3954-3959. (Pubitemid 37485014)
16. Fridkin SK. 2001. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin. Infect. Dis. 32:108-115. (Pubitemid 32150955)
17. Ghaznavi-Rad E, et al. 2010. Predominance and emergence of clones of hospital-acquired methicillin-resistant Staphylococcus aureus in Malaysia. J. Clin. Microbiol. 48:867-872.
18. Harmsen D, et al. 2003. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol. 41:5442-5448. (Pubitemid 37543228)
19. Hiramatsu K, et al. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136. (Pubitemid 27341646)
20. Hospital Infection Control Practices Advisory Committee. 1995. Recommendations for preventing the spread of vancomycin resistance. Infect. Control Hosp. Epidemiol. 16:105-113.
21. Kim M-N, Pai CH, Woo JH, Ryu JS, Hiramatsu K. 2000. Vancomycin- intermediate Staphylococcus aureus in Korea. J. Clin. Microbiol. 38:3879-3881.
22. Ko KS, et al. 2005. Distribution of major genotypes among methicillin-resistant Staphylococcus aureus clones in Asian countries. J. Clin. Microbiol. 43:421-426.
23. Noble WC, Virani Z, Cree RGA. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 72:195-198.
24. Oliveira GA, et al. 2001. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect. Control Hosp. Epidemiol. 22:443-448. (Pubitemid 32889277)
25. Peerayeh SN, Azimian A, Nejad QB, Kashi M. 2009. Prevalence of agr specificity groups among Staphylococcus aureus isolates from university hospitals in Tehran. Lab. Med. 40:27-29.
26. Périchon B, Courvalin P. 2009. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:4580-4587.
27. Ploy MC, Grélaud C, Martin C, de Lumley L, Denis F. 1998. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 351:1212. (Pubitemid 28171844)
28. Rehm SJ, Tice A. 2010. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus. Clin. Infect. Dis. 51(Suppl 2):S176-S182.
29. Saha B, Singh AK, Ghosh A, Bal M. 2008. Identification and characterization of a vancomycin resistant Staphylococcus aureus isolated from Kolkata (South Asia). J. Med. Microbiol. 57:72-79.
30. Shahsavan S, et al. 2011. Molecular analysis and antimicrobial susceptibility of methicillin resistant Staphylococcus aureus in one of the hospitals of Tehran University of Medical Sciences: high prevalence of sequence type 239 (ST239) clone. Acta Microbiol. Immunol. Hung. 58:31-39.
31. Sievert DM, et al. 2008. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin. Infect. Dis. 46:668-674. (Pubitemid 351321548)
32. Sola C, et al. 2012. Spread of epidemic MRSA-ST5-IV clone encoding PVL as a major cause of community onset staphylococcal infections in Argentinean children. PLoS One 7:e30487. doi:10.1371/journal.pone.0030487.
33. Tenover FC. 2008. Vancomycin-resistant Staphylococcus aureus: a perfect but geographically limited storm? Clin. Infect. Dis. 46:675-677. (Pubitemid 351321549)
34. Tenover FC, et al. 2004. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob. Agents Chemother. 48:275-280. (Pubitemid 38040208)
35. Thati V, Shivannavar CT, Gaddad SM. 2011. Vancomycin resistance among methicillin-resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. Indian J. Med. Res. 134:704-708.
36. Tiwari HK, Sen MR. 2006. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect. Dis. 6:156. doi:10.1186/1471-2334-6-156.
37. Walsh TR, Howe RA. 2002. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu. Rev. Microbiol. 56:657-675. (Pubitemid 35217470)
38. Weigel LM, et al. 2007. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob. Agents Chemother. 51:231-238. (Pubitemid 46047711)
39. Wenzel RP, Edmond MB. 1998. Vancomycin-resistant Staphylococcus aureus: infection control considerations. Clin. Infect. Dis. 27:245-251. (Pubitemid 28365744)
40. Zhu W, et al. 2008. Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. Antimicrob. Agents Chemother. 52:452-457. (Pubitemid 351170813)